1.C6, a new monoclonal antibody, reacts with the follicle-associated epithelium of calf ileal Peyer's patches.
Kana TOZAKI ; Junpei KIMURA ; Masahiro YASUDA ; Nobuyuki RYU ; Testuo NASU ; Anton PERNTHANER ; Wayne R HEIN
Journal of Veterinary Science 2013;14(1):1-6
The follicle-associated epithelium (FAE) of Peyer's patches (PPs) contains M cells that are important for reducing mucosal immune responses by transporting antigens into the underlying lymphoid tissue. We generated a monoclonal antibody (C6) that reacted with the FAE of calf ileal PPs, and analyzed the characteristics of C6 using immunohistochemistry and Western blotting. FAE of the ileal PP was stained with C6 during both late fetal developmental and postnatal stages. Neither the villous epithelial cell nor intestinal crypt basal cells were stained at any developmental stage. During the prenatal stages, FAE of the jejunal PP was C6-negative. However, a few C6-positive cells were distributed diffusely in some FAE of the jejunal PPs during the postnatal stages. The protein molecular weight of the antigen recognized by C6 was approximately 45 kDa. These data show that C6 is useful for identifying the FAE in ileal PPs and further suggest that differentiation of the FAE in these areas is independent of external antigens.
Animals
;
Antibodies, Monoclonal/*immunology
;
*Cattle
;
Fetus
;
Hybridomas
;
Ileum/*ultrastructure
;
Intestinal Mucosa/*immunology
;
Peyer's Patches/*immunology/ultrastructure
2.C6, a new monoclonal antibody, reacts with the follicle-associated epithelium of calf ileal Peyer's patches.
Kana TOZAKI ; Junpei KIMURA ; Masahiro YASUDA ; Nobuyuki RYU ; Testuo NASU ; Anton PERNTHANER ; Wayne R HEIN
Journal of Veterinary Science 2013;14(1):1-6
The follicle-associated epithelium (FAE) of Peyer's patches (PPs) contains M cells that are important for reducing mucosal immune responses by transporting antigens into the underlying lymphoid tissue. We generated a monoclonal antibody (C6) that reacted with the FAE of calf ileal PPs, and analyzed the characteristics of C6 using immunohistochemistry and Western blotting. FAE of the ileal PP was stained with C6 during both late fetal developmental and postnatal stages. Neither the villous epithelial cell nor intestinal crypt basal cells were stained at any developmental stage. During the prenatal stages, FAE of the jejunal PP was C6-negative. However, a few C6-positive cells were distributed diffusely in some FAE of the jejunal PPs during the postnatal stages. The protein molecular weight of the antigen recognized by C6 was approximately 45 kDa. These data show that C6 is useful for identifying the FAE in ileal PPs and further suggest that differentiation of the FAE in these areas is independent of external antigens.
Animals
;
Antibodies, Monoclonal/*immunology
;
*Cattle
;
Fetus
;
Hybridomas
;
Ileum/*ultrastructure
;
Intestinal Mucosa/*immunology
;
Peyer's Patches/*immunology/ultrastructure
3.Formation and modifying factors of atopy in early life.
Chinese Journal of Pediatrics 2004;42(2):150-151
Adult
;
Child
;
Diet
;
Female
;
Fetus
;
immunology
;
Humans
;
Hypersensitivity
;
embryology
;
immunology
;
Maternal Behavior
;
Pregnancy
;
immunology
;
Risk Factors
4.Differential expression of leukocyte common antigen in human fetal lymphoid organs.
Journal of Korean Medical Science 1995;10(1):14-23
To investigate the differential expression of various types of leukocyte common antigen (LCA) isoforms during development, we analyzed human fetal lymphoid organs, including the thymus, liver, spleen, and bone marrow from 14 weeks to 29 weeks of gestational age by immunohistochemical and flow cytometric methods. In fetal thymus, over 90% of thymocytes throughout the entire fetal life expressed CD45RO and CD45RB, while CD45RA was expressed only in less than 5% of thymocytes. This expression pattern of LCA isoforms was established by a gestational age of 14 weeks or earlier, and persisted throughout the fetal period. The tissue distribution was different from each isoform; CD45RO-positive thymocytes were found in both the cortex and medulla at the 14th week with low intensity, but was localized in the cortex with increasing fetal age. CD45RB-positive thymocytes distributed mainly in the medulla from early gestational age. Among extrathymic lymphoid organs, a small portion of lymphoid cells expressing leukocyte common antigens appeared first in the liver at 10-12 weeks of gestational age and was followed by a small number in the spleen and bone marrow by 13-15 weeks. All lymphoid cells in these extrathymic lymphoid organs at this stage were CD19+ B cells. The number of these CD19+ cells increased abruptly during the early period of mid-gestational age. The pattern of tissue distribution of each LCA isoform in the fetal liver and spleen correlated well with the patterns of quantitative analysis by flow cytometry. In summary we found that different LCA isoforms expressed in cell-type-specific pattern and showed different tissue distribution during the period of fetal development, and that LCA was the earliest antigen expressed by lymphocytes in the thymus and extrathymic lymphoid organs in our series.
Antigens, CD45/*analysis
;
Bone Marrow/immunology
;
Female
;
Fetus/*immunology
;
Flow Cytometry
;
Human
;
Immunoenzyme Techniques
;
Liver/immunology
;
Lymphoid Tissue/*immunology
;
Pregnancy
;
Spleen/immunology
5.In utero hematopoietic stem cell therapy.
Satoshi HAYASHI ; Alan W FLAKE
Yonsei Medical Journal 2001;42(6):615-629
In utero hematopoietic stem cell transplantation (IUHSCTx) is a promising approach for the treatment of a potentially large number of fetuses affected by congenital hematologic disorders. With technical advances in prenatal diagnosis and fetal intervention, the majority of these diseases can now be diagnosed early in gestation, allowing consideration of prenatal treatment. It, therefore, stands to reason that there is increasing interest in performing in utero hematopoietic stem cell transplantation at many centers around the world. Although the approach remains experimentally promising, expansion of clinical application will depend on improved understanding of the biological barriers to engraftment in the fetus as well as on the development of effective clinical strategies based on the hematopoietic biology of individual disorders.
Animal
;
Bioethics
;
Fetal Diseases/*surgery
;
Fetus/immunology
;
*Hematopoietic Stem Cell Transplantation/adverse effects
;
Human
;
Risk Factors
;
Transplantation Immunology
6.Establishment of genotyping method for fetal ABO group from pregnant maternal peripheral blood.
Yang YU ; Qian FEN ; Zi-Lin LIN ; Ji-Chun PAN ; Ting ZHANG ; Chun-Ya MA ; Xiao-Juan ZHANG ; Guo-Feng GE ; Xin CHEN ; Xiao-Zhen GUAN ; Le REN ; Dan SUN ; Li-Hui FU ; Qun LUO ; De-Qing WANG
Journal of Experimental Hematology 2009;17(5):1363-1367
This study was aimed to establish a genotyping method to detect ABO group gene of fetus from peripheral blood of pregnant women for prenatal diagnosis of hemolytic disease of newborn (HDN) resulting from ABO blood group incompatibility. 4 pairs of primers were designed according to ABO blood group gene DNA and mRNA sequences. 20 plasma DNA samples from healthy donors were extracted and amplified to explore the best conditions for plasma DNA extraction and PCR amplification. The O group plasma DNA was mixed with A group or B group plasmas by the ratios of 1:1, 2:1, 4:1, 8:1, 10:1, 20:1, 40:1, 100:1 to simulate the status of mixed ABO gene from pregnant maternal blood and to establish the mixed blood group ABO genotyping technology. The pregnant maternal blood samples with more than 30 weeks of gestation were selected for detecting the fetal ABO blood group genotype. The blood samples should be taken as possible as after birth for identification of ABO blood group and evaluation of sensitivity and accuracy of fetal ABO blood group genotyping technology through peripheral blood of pregnant women. The results indicated that the minimal amount of template DNA from single blood plasma for accuracy identification was at least about 0.625 ng, the DNA amount extracted from 500 microl of plasma could meet the requirement for PCR amplification. When the proportion of O group plasma DNA in mixed plasma DNA was
7.Hemangioblastic characteristics of fetal bone marrow-derived Flk1+ CD34- cells.
Hong GUO ; Zhi-gang ZHAO ; Jie-wen LIU ; Hui-shu CHEN ; Chun-hua ZHAO
Acta Academiae Medicinae Sinicae 2002;24(6):606-610
OBJECTIVETo investigate whether fetal bone marrow stromal cells have hemangioblastic characteristics.
METHODSHuman fetal bone marrow stromal cells (hfMSCs) were isolated and cultured. Immunophenotypes of hfMSCs were tested by FACS. hfMSCs seeded in the matrigel were induced with vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in vitro. Vascularization and hematopoiesis were detected with immunohistochemistry and electron microscope.
RESULTSThe typical properties of this CD34- stromal cell population were that 99% cells expressed Flk1 (vascular endothelial cell growth factor receptor 2) and tube structure was formed. In the process of induction, hfMSCs could give rise to CD34+ round cells.
CONCLUSIONSWe have demonstrated that fetal bone marrow stroma-derived Flk1+ CD34- cells could differentiate into vascular endothelial cells and hematopoietic cells, indicating that fetal bone marrow stroma-derived Flk1+ CD34- cells have hemangioblastic characteristics.
Antigens, CD34 ; immunology ; Bone Marrow Cells ; cytology ; immunology ; metabolism ; Cell Differentiation ; Cells, Cultured ; Fetus ; Fibroblast Growth Factor 2 ; metabolism ; Hematopoiesis ; Hematopoietic Stem Cells ; cytology ; immunology ; metabolism ; Humans ; Immunophenotyping ; Stromal Cells ; cytology ; immunology ; metabolism ; Vascular Endothelial Growth Factor Receptor-2 ; physiology
8.Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
Jae Won PARK ; Dae Joong KIM ; Jinhee KIM ; Chung Gyu PARK ; Eung Soo HWANG ; Chang Yong CHA
Journal of Korean Medical Science 2000;15(2):133-138
Human cytomegalovirus (HCMV) gB is known to play important roles in cell surface attachment, virion penetration, spread of infection from cell to cell, and provocation of neutralizing antibody. This study was performed to determine the role of anti-HCMV gB antibody in overall neutralizing response in patients with HCMV infection and healthy control with past infection. HCMV gB was stably expressed in 293 cells. With the stable cell line expressing gB as a specific immunosorbent, anti-gB antibody was removed from the current and past HCMV-infected sera and the remaining neutralizing activity was measured by plaque assay. It was shown that 19-50% of the total virus-neutralizing activity of sera with past HCMV infections was derived from anti-gB antibody, but anti-gB antibody had little effect on the total serum virus-neutralizing activity in patients currently infected with HCMV. This result suggests that neutralizing antibody to HCMV gB may reflect disease status.
Adult
;
Antibodies, Monoclonal
;
Antibodies, Viral/immunology*
;
Antibodies, Viral/blood
;
Antigens, Viral/immunology
;
Antigens, Viral/genetics
;
Cells, Cultured
;
Cytomegalovirus/immunology*
;
Cytomegalovirus Infections/prevention & control
;
Cytomegalovirus Infections/immunology*
;
Female
;
Fetus/cytology
;
Fibroblasts/cytology
;
Gene Expression Regulation, Viral/immunology
;
Human
;
Immunosorbents
;
Lung/cytology
;
Male
;
Middle Age
;
Neutralization Tests
;
Recombinant Proteins/genetics
;
Viral Envelope Proteins/immunology*
;
Viral Vaccines
9.A pilot study on establishment of human/pig hematopoietic chimera model in fetal and neonatal pigs.
Ying-Xia TAN ; Jie-Xi WANG ; Ming LI ; Yang-Pei ZHANG
Journal of Experimental Hematology 2005;13(4):673-676
This study was aimed to explore the feasibility of transplanting human cord blood stem cells (HSC) into pre-immune fetal and neonatal pigs, and to investigate the self-renewal of HSC in the recipient pigs. The fetus and neonate were manipulated in sterile separated room and human donor cells were injected into fetus via fetus muscle or umbilical vein (dissectted womb) or into neonate via umbilical vein before cutting it. Human CD45(+) cells s were detected by labeling with human anti-CD45 antibody and analyzed by fluorescence activated cell sorting (FACS). The results showed that tested pigs developed as well as control and a definite proportion of human cells existed in peripheral blood of chimeric pig on day 60 after transplantation. In conclusion, the fetus and neonate pigs can tolerate a definite proportion of human antigens, and to establish the human/pig model of hematopoietic chimerism is possible.
Animals
;
Animals, Newborn
;
Cord Blood Stem Cell Transplantation
;
methods
;
Fetus
;
Flow Cytometry
;
Humans
;
Leukocyte Common Antigens
;
blood
;
Models, Animal
;
Pilot Projects
;
Swine
;
Transplantation Chimera
;
blood
;
immunology
;
Transplantation, Heterologous
10.Human fetal heart-derived adherent cells with characteristics similar to mesenchymal progenitor cells.
Xiao-Xia JIANG ; Yong-Feng SU ; Xiu-Sen LI ; Yi ZHANG ; Ying WU ; Ning MAO
Journal of Experimental Hematology 2006;14(6):1191-1194
This study was aimed to investigate if human heart harbored a population of primitive undifferentiated cells with the characteristics of MPC. Cells were isolated from human fetal heart and were cultured under conditions appropriate for bone marrow-derived MPCs. Their morphology, phenotypes and functions were tested by methods developed for MPC from other sources. The results showed that morphologically, cells were spindle shaped and resembled fibroblasts. In their undifferentiated state, cells were CD73, CD105, CD29, CD44, HLA-ABC, CD166 positive and CD45, CD34, CD86, HLA-DR negative. When cultured in adipogenic, osteogenic or chondrogenic media, cells differentiated into adipocytes, osteocytes and chondrocytes respectively. They could be extensively expanded in vitro and exhibited very low immunogenicity as evaluated by T cell proliferation assays. It is concluded that cells isolated from fetal heart possess similarity to their adult and fetal bone marrow counterparts in morphologic, immunophenotypic, and functional characteristics.
Bone Marrow Cells
;
cytology
;
Cell Adhesion
;
Cell Differentiation
;
Cells, Cultured
;
Fetal Heart
;
cytology
;
Fetus
;
Humans
;
Mesenchymal Stromal Cells
;
cytology
;
immunology
;
Multipotent Stem Cells
;
physiology